Canopy Growth Corporation vs Merck & Company, Inc. — Stock Comparison

CGC
Canopy Growth Corporation
$1.13
▲ 1.80%
vs
MRK
Merck & Company, Inc.
$112.16
▲ 2.73%
Q·Score Winner
Merck & Company, Inc.
MRK6.7/10vs 4/10

Q·Score Breakdown

4
Bearish
Overall
6.7
Neutral
0.2
Quality
6.2
8.2
Health
7
3
Growth
6.2
6.3
Valuation
7.2
3.3
Sentiment
7.1
CGC

Clean balance sheet with low leverage (0.3× debt-to-equity).

currently unprofitable (-117% margin).

MRK

Forward P/E of 11.5× is low relative to sector peers.

Analyst Consensus

HOLD
Target $1.81 (+60.0%)
1 analysts
BUY
Target $129.74 (+15.7%)
27 analysts

Fundamentals

CGC
MRK
Trailing P/E
31.5×
-15.5×
Forward P/E
11.5×
-117.3%
Profit Margin
13.6%
26.6%
Gross Margin
76.6%
-48.5%
ROE
-0.3%
Revenue Growth
4.9%
Earnings Growth
2.32
Beta
0.28
Price / Book
$507M
Market Cap
$277.0B
$1 – $2
52-Week Range
$73 – $125

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →